Trial site
Yale-New Haven Health System
- 11running trials
The trials here
What the 11 trials at this site are about, from their registry records.
- Conditions
- Amyloidosis2 trials
- Aortic stenosis2 trials
- Heart failure2 trials
- Gaucher disease1 trial
- Multiple system atrophy1 trial
- Osteonecrosis (avascular necrosis)1 trial
- Spinal muscular atrophy1 trial
- Phase
- Phase 31 trial
- Status
- Recruiting4 trials
- Active, not recruiting3 trials
- Enrolling by invitation3 trials
- Not yet recruiting1 trial
- Lead sponsor
- Yale University7 trials
- AgileMD, Inc.1 trial
- H. Lundbeck A/S1 trial
- Medicines3601 trial
- Novartis Pharmaceuticals1 trial
Running trials
Not yet recruiting
Recruiting
Advancing Stillbirth Prevention Through Innovative Risk Evaluation (ASPIRE) Clinical Study
Enrolling by invitation
Enrolling by invitation
Deep Learning-enhanced Personalized Monitoring of Aortic Stenosis - The DETECT-AS Prognostic Study
Recruiting
Enrolling by invitation
Deep Learning Enhanced Detection of Aortic Stenosis - The DETECT-AS-Diagnostic Study
Active, not recruiting
Active, not recruiting
A Rapid Diagnostic of Risk in Hospitalized Patients Using Machine Learning
Active, not recruiting
A Trial of Amlenetug (Lu AF82422) in Participants With Multiple System Atrophy (MSA)
Recruiting
Real-Time Monitoring of Heart Failure Across the Yale New Haven Health System
Recruiting
Registry of Patients With a Diagnosis of Spinal Muscular Atrophy (SMA)
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Aortic stenosis2 recruiting
- Heart failure2 recruiting
- Amyloidosis1 recruiting
- Gaucher disease1 recruiting
- Osteonecrosis (avascular necrosis)1 recruiting
- Spinal muscular atrophy1 recruiting
Site data: ClinicalTrials.govUpdated 15 Nov 2026